Back to Search
Start Over
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy
- Source :
- Science Translational Medicine; November 2020, Vol. 12 Issue: 568
- Publication Year :
- 2020
-
Abstract
- Natural killer cells derived from iPSCs prime T cells for anti–PD-1 immune checkpoint therapy.
Details
- Language :
- English
- ISSN :
- 19466234 and 19466242
- Volume :
- 12
- Issue :
- 568
- Database :
- Supplemental Index
- Journal :
- Science Translational Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs54573886
- Full Text :
- https://doi.org/10.1126/scitranslmed.aaz5618